Seres Therapeutics
MCRB
#8798
Rank
NZ$0.15 B
Marketcap
$0.94
Share price
-7.16%
Change (1 day)
-52.93%
Change (1 year)

Seres Therapeutics (MCRB) Fails to deliver data

Key failure to deliver metrics for Seres Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Seres Therapeutics (MCRB) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Seres Therapeutics (MCRB) - since 2015

Volume in USD (price x number of shares), data since 2015

Seres Therapeutics (MCRB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$8.23 M-0.78%
2023NZ$8.29 M67.24%
2022NZ$4.96 M-71.89%
2021NZ$17.65 M6.11%
2020NZ$16.63 M760.55%
2019NZ$1.93 M-18.95%
2018NZ$2.38 M116.25%
2017NZ$1.1 M-96.05%
2016NZ$27.94 M-14.24%
2015NZ$32.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0 MNZ$2.21 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.95 MNZ$8.96 M๐Ÿ‡บ๐Ÿ‡ธ USA